상세 보기
IEEE Transactions on Emerging Topics in Computing
ISSN
P 2168-6750
출판사
IEEE Computer Society
국가
USA
발행 상태
활성
데이터베이스 수록 정보
CiteScore 2014-2025 (12년)
JCR 2016-2025 (10년)
SCIE 2016-2026 (11년)
Scopus 2013-2026 (14년)
SJR 2014-2020, 2022-2025 (11년)
전체 16건 중 1번부터 10번까지의 결과를 표시합니다.
2025
Article
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
- Elimova, Elena ;
- Ajani, Jaffer ;
- Burris, Howard ;
- Denlinger, Crystal S. ;
- Iqbal, Syma ;
- 외 12명
- 2025-07
- The Lancet Oncology
- ELSEVIER SCIENCE INC
Article
Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study
- Ahn, Hee Kyung ;
- Kim, Ji-Yeon ;
- Lee, Kyung-Hun ;
- Kim, Gun Min ;
- Kang, Seok Yun ;
- ... Park, In Hae ;
- 외 15명
- 2025-03
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2022
Article
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT) : a randomised, double-blind, placebo-controlled, phase 2 study
- Wainberg, Zev A. ;
- Enzinger, Peter C. ;
- Kang, Yoon-Koo ;
- Qin, Shukui ;
- Yamaguchi, Kensei ;
- ... Oh, Sang Cheul ;
- 외 15명
- 2022-11
- The Lancet Oncology
- ELSEVIER SCIENCE INC
Article
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
- Kang, Yoon-Koo ;
- Chen, Li-Tzong ;
- Ryu, Min-Hee ;
- Oh, Do-Youn ;
- Oh, Sang Cheul ;
- 외 20명
- 2022-02
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2020
Article
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
- Youn, Jin Won ;
- Hur, Soo-Young ;
- Woo, Jung Won ;
- Kim, Yong-Man ;
- Lim, Myong Cheol ;
- ... Lee, Jae-Kwan ;
- 외 11명
- 2020-12
- The Lancet Oncology
- ELSEVIER SCIENCE INC
Article
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial
- Catenacci, Daniel V. T. ;
- Kang, Yoon-Koo ;
- Park, Haeseong ;
- Uronis, Hope E. ;
- Lee, Keun-Wook ;
- ... Oh, Sang Cheul ;
- 외 28명
- 2020-08
- The Lancet Oncology
- ELSEVIER SCIENCE INC
Article
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
- Kang, Yoon-Koo ;
- Chin, Keisho ;
- Chung, Hyun Cheol ;
- Kadowaki, Shigenori ;
- Oh, Sang Cheul ;
- 외 14명
- 2020-08
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2018
Article
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC
- Togawa, Kayo ;
- Ahn, Hyeong Sik ;
- Auvinen, Anssi ;
- Bauer, Andrew J. ;
- Brito, Juan P. ;
- 외 11명
- 2018-10
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2016
Article
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
- Kim, Seok Jin ;
- Yoon, Dok Hyun ;
- Jaccard, Arnaud ;
- Chng, Wee Joo ;
- Lim, Soon Thye ;
- ... Park, Yong ;
- ... Choi, Chul Won ;
- 외 24명
- 2016-03
- The Lancet Oncology
- ELSEVIER SCIENCE INC
2014
Article
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- Wilke, Hansjochen ;
- Muro, Kei ;
- Van Cutsem, Eric ;
- Oh, Sang-Cheul ;
- Bodoky, Gyoergy ;
- 외 15명
- 2014-10
- The Lancet Oncology
- ELSEVIER SCIENCE INC
1